Research Quality You Can Verify

Base Peptides prioritizes compound identity, purity, consistency, transparency, and analytical testing for laboratory research. Verifiable quality starts with understanding what a document establishes—and what it does not.

View Current Testing

Our Quality Standard

Our quality standard centers on clear compound identification, relevant analytical evidence, and responsible interpretation of the documentation available.

Compound identity

Evaluate whether the tested material is consistent with the stated compound using the identity measurements and reference information in its original report.

Purity

Interpret purity according to the reported analytical method, sample, and acceptance criteria—not as a universal statement about every product or batch.

Consistency

Compare like-for-like measurements across documented samples and lots. A single result does not establish consistency across untested batches.

Third-party analytical testing

Research compounds are evaluated through third-party analytical testing for specified attributes. Our product-specific summaries document reported results for the compounds and lots identified in each document.

Transparent documentation

Keep original documents available, distinguish examples from verified results, and avoid filling gaps with assumed dates, results, or batch identifiers.

Proper handling & storage

Follow compound-specific handling and storage information supplied with the material. Researchers should document storage conditions and avoid assuming that one storage protocol applies to all compounds.

The October 2, 2026 summaries listed below report RP-HPLC purity above 99% for their identified samples and lots. These reported results support a sample-specific discussion of 99%+ purity—not a blanket claim about every product, formulation, or current inventory lot.

Analytical Testing

The current testing summaries describe third-party analytical testing using RP-HPLC for purity and LC-MS for identity. Each result should be read alongside its method and the sample or lot identified in the document. Different measurements answer different questions; no single result establishes every aspect of quality.

Current Testing & COAs

This library contains 27 Base Peptides testing summaries dated October 2, 2026. Each PDF preserves its page from the supplied packet unchanged. These are customer-facing summaries of reported third-party results, not original laboratory-issued COAs or independent certifications. Values below are transcribed from those summaries and apply only to the identified product and lot. Earlier sample/template documents are not presented here as current testing evidence.

Existing COA & batch disclosure policy

Understanding Testing

HPLC: chromatographic separation

The summaries list reverse-phase high-performance liquid chromatography (RP-HPLC) for purity. HPLC separates components and measures detector responses. Purity percentages are method-dependent and should not automatically be interpreted as total mass purity, potency, or biological efficacy.

Mass spectrometry: identity information

The summaries list liquid chromatography–mass spectrometry (LC-MS) for identity. It combines chromatographic separation with molecular-ion measurements to support identity assessment. Identity evidence alone does not establish purity or safety.

Read the original report in context

Analytical results represent the tested sample and must be interpreted according to the original report, including methods, limitations, specifications, and sample identifiers. A document for one compound or sample must not be assumed to verify another formulation, blend, batch, or current inventory.

For laboratory research use only. Not for human consumption. Testing documentation does not establish safety, clinical efficacy, suitability for human use, or regulatory approval.